Brain Matters Research Inc.   Report issue

For profit Phase 1
Founded: Delray Beach FL United States (2004)

Organization Overview

First Clinical Trial
2010
NCT01716637
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 7